2 completed, 2 withdrawn, 1 terminated, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 2, Withdrawn 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Pegylated Interferon: new trials by email Literature Review of Pegylated Interferon trials Research Report on Pegylated Interferon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066) Grazoprevir/Elbasvir, Boceprevir, PegIntron - Hepatitis C | Phase 3 | Withdrawn | Merck Sharp & Dohme LLC | 2014-11-01 | 2015-10-14 | |
| Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients BI 201335, ribavirin, BI 207127 - Hepatitis C, Chronic | Phase 3 | Withdrawn | Boehringer Ingelheim | 2013-05-01 | 2014-01-23 | |
| Long Term Vitamin D Therapy in HCV Treated Patients Vitamin D - Chronic Hepatitis C | Phase 3 | Terminated | Dr. Nadia AbdelAaty AbdelKader | 100 | 2012-04-01 | 2013-11-28 |
| Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus Daclatasvir, Ribavirin, PEG-Interferon alfa 2a - Hepatitis C, Genotype 1 | Phase 3 | Completed | Bristol-Myers Squibb | 549 | 2011-12-01 | 2016-01-29 |
| Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C pegylated interferon alpha 2a YPEG-IFN α-2a 180mcg - Self Efficacy, Hepatitis C | Phase 2 / Phase 3 | Unknown | BioGeneric Pharma | 300 | 2010-11-01 | 2011-04-04 |
| HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. Ribavirin, Pegylated Interferon - Opiate Dependence, Hepatitis | Phase 3 | Completed | Sorlandet Hospital HF | 10 | 2006-03-01 | 2008-03-28 |
Hepatitis C (4) · Hepatitis C, Chronic (2) · Hepatitis (1) · Opioid-Related Disorders (1)
BioGeneric Pharma (1) · Boehringer Ingelheim (1) · Bristol-Myers Squibb (1) · Dr. Nadia AbdelAaty AbdelKader (1) · Merck Sharp & Dohme LLC (1) · Sorlandet Hospital HF (1)
Australia (2) · Egypt (2) · Spain (2) · Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Norway (1) · Puerto Rico (1) · Russia (1) · Sweden (1) · United Kingdom (1)
Amany Y Elkazaz (1) · Dina Sabry (1) · Gamal Esmat, MD (1) · Mohamed Ghussin (1) · Mohamed Karim F Ashour, MD (1) · Mohamed M Tawfic (1) · Nadia A Abdelkader (1) · Oistein Kristensen, MD (1) · Yehia M Korriem (1)
2014 (1)